GX Acquisition Corp. (NASDAQ:GXGX)

Stock Price: $1.57
-0.09 (-5.42%)
Updated Nov 25, 2022 06:00 PM GMT+0000
Overview
Financials
Statistics
Profile
Chart
Market Cap 227.67M
Revenue 0
Gross Profit 0
Shares Out 145.01M
EPS (ttm)
PE Ratio 0.0000
Forward PE -2.3609
Dividend Rate (ttm) 0.0000
Dividend Yield 0.0000
Trading Day Nov 25
Last Price $1.57
Previous Close $1.66
Change ($) -0.09
Change (%) -5.42%
Day's Open 1.66
Day's Range Market Closed
Day's Volume 0
52 Week Range 1.35 - 13.19

About GX Acquisition Corp.

Celularity, Inc. headquartered in Florham Park, N.J., is a clinical stage biotechnology company leading the next evolution in cellular medicine by developing off-the-shelf placental-derived allogeneic cell therapies, including unmodified natural killer (NK) cells, genetically-modified NK cells, T-cells engineered with a CAR (CAR T-cells), and mesenchymal-like adherent stromal cells (ASCs) targeting indications across cancer, infectious and degenerative diseases.

In addition, Celularity develops and manufactures innovative biomaterials also derived from the postpartum placenta. Celularity believes that by harnessing the placenta’s unique biology and ready availability, it will be able to develop therapeutic solutions that address significant unmet global needs for effective, accessible, and affordable therapies.

News

No news found.

Quick info

Country
United States
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Employees
225
CEO
Robert Joseph Hariri
Address
170 Park Avenue
Florham Park
NJ
07932
Phone
9087682170
Website
celularity.com
Ticker Symbol
CELU
Reporting Currency
USD